ÿþ<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns="http://www.w3.org/TR/REC-html40"> <head> <meta http-equiv=Content-Type content="text/html; charset=unicode"> <meta name=ProgId content=Word.Document> <meta name=Generator content="Microsoft Word 12"> <meta name=Originator content="Microsoft Word 12"> <link rel=File-List href="news-Dateien/filelist.xml"> <link rel=Edit-Time-Data href="news-Dateien/editdata.mso"> <!--[if !mso]> <style> v\:* {behavior:url(#default#VML);} o\:* {behavior:url(#default#VML);} w\:* {behavior:url(#default#VML);} .shape {behavior:url(#default#VML);} </style> <![endif]--> <title>Workgroup Prof. Mueller</title> <o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="country-region"/> <o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="place"/> <link rel=themeData href="news-Dateien/themedata.thmx"> <link rel=colorSchemeMapping href="news-Dateien/colorschememapping.xml"> <!--[if gte mso 9]><xml> <w:WordDocument> <w:Zoom>90</w:Zoom> <w:SpellingState>Clean</w:SpellingState> <w:GrammarState>Clean</w:GrammarState> <w:TrackMoves>false</w:TrackMoves> <w:TrackFormatting/> <w:HyphenationZone>21</w:HyphenationZone> <w:ValidateAgainstSchemas/> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF/> <w:LidThemeOther>DE</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables/> <w:SnapToGridInCell/> <w:WrapTextWithPunct/> <w:UseAsianBreakRules/> <w:DontGrowAutofit/> <w:SplitPgBreakAndParaMark/> <w:DontVertAlignCellWithSp/> <w:DontBreakConstrainedForcedTables/> <w:DontVertAlignInTxbx/> <w:Word11KerningPairs/> <w:CachedColBalance/> </w:Compatibility> <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel> <m:mathPr> <m:mathFont m:val="Cambria Math"/> <m:brkBin m:val="before"/> <m:brkBinSub m:val="&#45;-"/> <m:smallFrac m:val="off"/> <m:dispDef/> <m:lMargin m:val="0"/> <m:rMargin m:val="0"/> <m:defJc m:val="centerGroup"/> <m:wrapIndent m:val="1440"/> <m:intLim m:val="subSup"/> <m:naryLim m:val="undOvr"/> </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false" DefSemiHidden="false" DefQFormat="false" LatentStyleCount="267"> <w:LsdException Locked="false" QFormat="true" Name="Normal"/> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"/> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 2"/> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 3"/> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 4"/> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 5"/> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 6"/> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 7"/> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 8"/> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 9"/> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="caption"/> <w:LsdException Locked="false" QFormat="true" Name="Title"/> <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/> <w:LsdException Locked="false" QFormat="true" Name="Subtitle"/> <w:LsdException Locked="false" Priority="99" Name="Hyperlink"/> <w:LsdException Locked="false" QFormat="true" Name="Strong"/> <w:LsdException Locked="false" QFormat="true" Name="Emphasis"/> <w:LsdException Locked="false" Priority="99" Name="Plain Text"/> <w:LsdException Locked="false" Priority="99" Name="Normal (Web)"/> <w:LsdException Locked="false" Priority="99" Name="No List"/> <w:LsdException Locked="false" Priority="99" Name="Balloon Text"/> <w:LsdException Locked="false" Priority="99" SemiHidden="true" Name="Placeholder Text"/> <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"/> <w:LsdException Locked="false" Priority="60" Name="Light Shading"/> <w:LsdException Locked="false" Priority="61" Name="Light List"/> <w:LsdException Locked="false" Priority="62" Name="Light Grid"/> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"/> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"/> <w:LsdException Locked="false" Priority="65" Name="Medium List 1"/> <w:LsdException Locked="false" Priority="66" Name="Medium List 2"/> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"/> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"/> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"/> <w:LsdException Locked="false" Priority="70" Name="Dark List"/> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"/> <w:LsdException Locked="false" Priority="72" Name="Colorful List"/> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"/> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"/> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"/> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"/> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"/> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"/> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"/> <w:LsdException Locked="false" Priority="99" SemiHidden="true" Name="Revision"/> <w:LsdException Locked="false" Priority="34" QFormat="true" Name="List Paragraph"/> <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"/> <w:LsdException Locked="false" Priority="30" QFormat="true" Name="Intense Quote"/> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"/> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"/> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"/> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"/> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"/> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"/> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"/> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"/> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"/> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"/> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"/> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"/> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"/> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"/> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"/> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"/> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"/> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"/> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"/> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"/> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"/> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"/> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"/> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"/> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"/> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"/> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"/> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"/> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"/> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"/> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"/> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"/> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"/> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"/> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"/> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"/> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"/> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"/> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"/> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"/> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"/> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"/> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"/> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"/> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"/> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"/> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"/> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"/> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"/> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"/> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"/> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"/> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"/> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"/> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"/> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"/> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"/> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"/> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"/> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"/> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"/> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"/> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"/> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"/> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"/> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"/> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"/> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"/> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"/> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"/> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"/> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"/> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"/> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"/> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"/> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"/> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"/> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"/> <w:LsdException Locked="false" Priority="19" QFormat="true" Name="Subtle Emphasis"/> <w:LsdException Locked="false" Priority="21" QFormat="true" Name="Intense Emphasis"/> <w:LsdException Locked="false" Priority="31" QFormat="true" Name="Subtle Reference"/> <w:LsdException Locked="false" Priority="32" QFormat="true" Name="Intense Reference"/> <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"/> <w:LsdException Locked="false" Priority="37" SemiHidden="true" UnhideWhenUsed="true" Name="Bibliography"/> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/> </w:LatentStyles> </xml><![endif]--><!--[if !mso]><object classid="clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=ieooui></object> <style> st1\:*{behavior:url(#ieooui) } </style> <![endif]--> <style> <!-- /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-520092929 1073786111 9 0 415 0;} @font-face {font-family:Tahoma; panose-1:2 11 6 4 3 5 4 4 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-520081665 -1073717157 41 0 66047 0;} @font-face {font-family:Verdana; panose-1:2 11 6 4 3 5 4 4 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-1593833729 1073750107 16 0 415 0;} @font-face {font-family:Consolas; panose-1:2 11 6 9 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:modern; mso-font-pitch:fixed; mso-font-signature:-520092929 1073806591 9 0 415 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:"Times New Roman";} h1 {mso-style-priority:9; mso-style-unhide:no; mso-style-qformat:yes; mso-style-link:"Überschrift 1 Zchn"; mso-margin-top-alt:auto; margin-right:0cm; mso-margin-bottom-alt:auto; margin-left:0cm; mso-pagination:widow-orphan; mso-outline-level:1; font-size:24.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; font-weight:bold;} h2 {mso-style-noshow:yes; mso-style-priority:9; mso-style-qformat:yes; mso-style-link:"Überschrift 2 Zchn"; mso-margin-top-alt:auto; margin-right:0cm; mso-margin-bottom-alt:auto; margin-left:0cm; mso-pagination:widow-orphan; mso-outline-level:2; font-size:18.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; font-weight:bold;} a:link, span.MsoHyperlink {mso-style-priority:99; color:blue; text-decoration:underline; text-underline:single;} a:visited, span.MsoHyperlinkFollowed {mso-style-noshow:yes; mso-style-priority:99; color:blue; text-decoration:underline; text-underline:single;} p.MsoPlainText, li.MsoPlainText, div.MsoPlainText {mso-style-priority:99; mso-style-unhide:no; mso-style-link:"Nur Text Zchn"; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.5pt; font-family:Consolas; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-fareast-language:EN-US;} p {mso-style-priority:99; mso-style-unhide:no; mso-margin-top-alt:auto; margin-right:0cm; mso-margin-bottom-alt:auto; margin-left:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman","serif"; mso-fareast-font-family:"Times New Roman";} p.MsoAcetate, li.MsoAcetate, div.MsoAcetate {mso-style-priority:99; mso-style-unhide:no; mso-style-link:"Sprechblasentext Zchn"; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:8.0pt; font-family:"Tahoma","sans-serif"; mso-fareast-font-family:"Times New Roman";} span.berschrift1Zchn {mso-style-name:"Überschrift 1 Zchn"; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Überschrift 1"; mso-ansi-font-size:24.0pt; mso-bidi-font-size:24.0pt; mso-font-kerning:18.0pt; font-weight:bold;} span.berschrift2Zchn {mso-style-name:"Überschrift 2 Zchn"; mso-style-noshow:yes; mso-style-priority:9; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Überschrift 2"; mso-ansi-font-size:18.0pt; mso-bidi-font-size:18.0pt; font-weight:bold;} span.NurTextZchn {mso-style-name:"Nur Text Zchn"; mso-style-priority:99; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:"Nur Text"; mso-ansi-font-size:10.5pt; mso-bidi-font-size:10.5pt; font-family:Consolas; mso-ascii-font-family:Consolas; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Consolas; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-fareast-language:EN-US;} span.SprechblasentextZchn {mso-style-name:"Sprechblasentext Zchn"; mso-style-priority:99; mso-style-unhide:no; mso-style-locked:yes; mso-style-link:Sprechblasentext; mso-ansi-font-size:8.0pt; mso-bidi-font-size:8.0pt; font-family:"Tahoma","sans-serif"; mso-ascii-font-family:Tahoma; mso-hansi-font-family:Tahoma; mso-bidi-font-family:Tahoma;} span.style11 {mso-style-name:style11; mso-style-unhide:no;} span.SpellE {mso-style-name:""; mso-spl-e:yes;} span.GramE {mso-style-name:""; mso-gram-e:yes;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-size:10.0pt; mso-ansi-font-size:10.0pt; mso-bidi-font-size:10.0pt;} @page WordSection1 {size:595.3pt 841.9pt; margin:70.85pt 70.85pt 2.0cm 70.85pt; mso-header-margin:35.4pt; mso-footer-margin:35.4pt; mso-paper-source:0;} div.WordSection1 {page:WordSection1;} --> </style> <!--[if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Normale Tabelle"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman","serif";} </style> <![endif]--><!--[if gte mso 9]><xml> <o:shapedefaults v:ext="edit" spidmax="32770"/> </xml><![endif]--><!--[if gte mso 9]><xml> <o:shapelayout v:ext="edit"> <o:idmap v:ext="edit" data="1"/> </o:shapelayout></xml><![endif]--> </head> <body lang=DE link=blue vlink=blue style='tab-interval:35.4pt'> <div class=WordSection1> <div align=center> <table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=800 style='width:600.0pt;mso-cellspacing:0cm;mso-yfti-tbllook:1184;mso-padding-alt: 0cm 5.4pt 0cm 5.4pt'> <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal align=center style='margin-bottom:13.5pt;text-align:center'><span style='font-size:13.5pt;font-family:"Arial","sans-serif"'><br style='mso-special-character:line-break'> <![if !supportLineBreakNewLine]><br style='mso-special-character:line-break'> <![endif]><b><o:p></o:p></b></span></p> <p class=MsoNormal align=center style='margin-bottom:13.5pt;text-align:center'><b><u><span lang=EN-US style='font-size:16.0pt;font-family:"Arial","sans-serif"; mso-ansi-language:EN-US'>News:<o:p></o:p></span></u></b></p> <p class=MsoNormal align=center style='margin-bottom:13.5pt;text-align:center'><b><span lang=EN-US style='font-size:16.0pt;font-family:"Arial","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal align=center style='margin-bottom:13.5pt;text-align:center'><b><span lang=EN-US style='font-size:13.5pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal><span class=SpellE><b style='mso-bidi-font-weight:normal'><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'>Nano</span></b></span><b style='mso-bidi-font-weight: normal'><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'> Workshop in Brazil  4/5 April 2011<o:p></o:p></span></b></p> <p class=MsoNormal><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p> <p class=MsoNormal><span class=SpellE><span lang=EN-GB style='font-size:10.0pt; font-family:"Verdana","sans-serif";mso-ansi-language:EN-GB'>Sindusfarma</span></span><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'> <b style='mso-bidi-font-weight:normal'>- </b><span class=SpellE><strong><span style='font-family:"Verdana","sans-serif"; font-weight:normal;mso-bidi-font-weight:bold'>Sindicato</span></strong></span><strong><span style='font-family:"Verdana","sans-serif";font-weight:normal;mso-bidi-font-weight: bold'> <span class=SpellE>da</span> <span class=SpellE>Indústria</span> de <span class=SpellE>Produtos</span> <span class=SpellE>Farmacêuticos</span> no Estado de São Paulo</span></strong><b style='mso-bidi-font-weight:normal'> -</b> (<a href="http://www.sindusfarmacomunica.org.br/" target="_top">http://www.sindusfarmacomunica.org.br/</a> ), the pharmaceutical industry organization in Brazil, organized for the second time after 2010 a workshop on applied nanotechnology (<a href="sindusp.pdf">click for program</a>). The workshop was addressed to researchers from pharmaceutical, cosmetic and <span class=SpellE>nutraceutical</span> industry, but also from academic research institutions. It took place at the headquarters of <span class=SpellE>Sindusfarma</span>, <span class=SpellE>Rua</span> <span class=SpellE><span class=style11>Alvorada</span></span><span class=style11>, 1280  Vila <span class=SpellE>Olímpia</span> - São Paulo/SP</span>. Speakers were:<o:p></o:p></span></p> <p class=MsoNormal><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'>Cornelia Keck, <span class=SpellE>Freie</span> <span class=SpellE>Universität</span> Berlin and Dr. <span class=SpellE>Rimpler</span> GmbH Germany<o:p></o:p></span></p> <p class=MsoNormal><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'>Rainer H. Müller, <span class=SpellE>Freie</span> <span class=SpellE>Universität</span> Berlin, and founder of <span class=SpellE>PharmaSol</span> GmbH Germany<o:p></o:p></span></p> <p class=MsoNormal><span class=SpellE><span lang=EN-GB style='font-size:10.0pt; font-family:"Verdana","sans-serif";mso-ansi-language:EN-GB'>Vinod</span></span><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'> Shah, consultant, prev. at Food and Drug Administration (FDA) in the US<o:p></o:p></span></p> <p class=MsoNormal><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'>Salomon <span class=SpellE>Stavchansky</span>, College of Pharmacy, University of Texas<o:p></o:p></span></p> <p class=MsoNormal><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'>There were about 40 <span class=GramE>participants,</span> abstracts of the posters presented are published in <span class=SpellE>Fármacos</span> &amp; <span class=SpellE>Medicamentos</span>, <span class=SpellE>Número</span> 65, 2011, ISSN 1807-1678 (<a href="sindusa.pdf">click for abstracts</a>).<o:p></o:p></span></p> <p class=MsoNormal><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'>It was the first time for <span class=SpellE>Sindusfarma</span> to organize a workshop with a scientific poster session, in conjunction with the University of Sao Paulo (USP). Intention was to stimulate transfer from academic research results to industry and marketed products. The third workshop is scheduled for spring 2013.<o:p></o:p></span></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; color:black;mso-themecolor:text1;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; color:black;mso-themecolor:text1;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; color:black;mso-themecolor:text1;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; color:black;mso-themecolor:text1;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; color:black;mso-themecolor:text1;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; color:black;mso-themecolor:text1;mso-ansi-language:EN-US'>3rd Science to Market conference in Vienna 2010:<o:p></o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; color:black;mso-themecolor:text1;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black; mso-themecolor:text1;mso-ansi-language:EN-US'><a href="http://www.muller-berlin.com/EAPB2010.PDF">click here for full article</a><o:p></o:p></span></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; color:black;mso-themecolor:text1;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; color:black;mso-themecolor:text1;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; color:black;mso-themecolor:text1;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; color:black;mso-themecolor:text1;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; color:black;mso-themecolor:text1;mso-ansi-language:EN-US'>EAPB organizes 2nd Science to market conference:<o:p></o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black; mso-themecolor:text1;mso-ansi-language:EN-US'>The EAPB was founded in Berlin in 2000, among the foundation members were pharmacists from the Institute of Pharmacy, <span class=SpellE>Freie</span> <span class=SpellE>Universität</span> (FU) Berlin. Prof. Müller from the Berlin pharmacy institute was the first president, the location of EAPB was at the <span class=SpellE>Freie</span> <span class=SpellE>Universität</span> Berlin (now moving away from Berlin). Meanwhile EAPB established as the leading biotechnology organization in Europe, and has established its own conference  Science to Market . Below you find the press release for the 2<sup>nd</sup> S2M in Hannover 2009.<o:p></o:p></span></p> <p class=MsoNormal style='text-align:justify'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black; mso-themecolor:text1;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p> <p class=MsoNormal style='text-align:justify'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";color:black; mso-themecolor:text1;mso-ansi-language:EN-US'><a href="http://www.muller-berlin.com/EAPB2009.PDF">click here for full article</a><o:p></o:p></span></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'>Cosmetic Innovation Award - April 2009:<o:p></o:p></span></b></p> <p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'>For the 7th time the &quot;European Innovation Award for Cosmetics and Chemical <span class=SpellE>Excipients</span>&quot; was awarded in the categories innovative &quot;naturals&quot;, &quot;<span class=SpellE>functionals</span>/recipients&quot; and &quot;most innovative marketed product&quot; of the year. The award was initiated by BSB Dr. Riedel Hamburg, and is supported by the cosmetic industry. Two juries decide about the winners. This year the award ceremony took place in Munich on 22 April 2008. In the category &quot;<span class=SpellE>functionals</span>/recipients&quot; the first award was given for &quot;<span class=SpellE>Symhelios</span> 1031&quot; to <span class=SpellE>Symrise</span>, the 2nd for the development of &quot;<span class=SpellE>Nanodiamonds</span>&quot; to <span class=SpellE>PharmaSol</span>, represented by Dr. C. Keck Head R&amp;D, the 3rd award for &quot;<span class=SpellE>Luviquat</span> Sensation&quot; to BASF. Scientific cooperation partner of <span class=SpellE>PharmaSol</span> was Prof. R.H. Müller. Most innovative <span class=SpellE>üproduct</span> of the year was the &quot;<span class=SpellE>Mastercreme</span>&quot; by <span class=SpellE>Juvena</span>, 1st award in the category &quot;naturals&quot; was given to Arch for the product &quot;<span class=SpellE>Metabiotics</span> <span class=SpellE>Resveratrol</span>&quot;. More detailed Info: </span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><a href="http://www.bsb-cosmetic.de/de/2009.htm"><span lang=EN-US style='mso-ansi-language:EN-US'>http://www.bsb-cosmetic.de/de/2009.htm</span></a></span><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p></o:p></span></p> <p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-no-proof:yes'><img border=0 width=775 height=580 id="_x0000_i1037" src="news-Dateien/basf2009.jpg"></span><span lang=EN-US style='font-size: 10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language:EN-US'><o:p></o:p></span></p> <p class=MsoNormal align=center style='text-align:center'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-US'>Picture of the innovation award winners 2009<o:p></o:p></span></p> <p class=MsoNormal align=center style='text-align:center'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-US'><o:p>&nbsp;</o:p></span></p> <p class=MsoNormal align=center style='text-align:center'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-US'>Last row: very right: Dr. Riedel - initiator of the awards<o:p></o:p></span></p> <p class=MsoNormal align=center style='text-align:center'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-US'>Middle row: Dr. Keck/<span class=SpellE>PharmaSol</span> GmbH Berlin and Prof. Müller/<span class=SpellE>Freie</span> <span class=SpellE>Universität</span> Berlin (2nd and 3rd from left), Dr. Gruber/Arch (very right)<o:p></o:p></span></p> <p class=MsoPlainText align=center style='text-align:center'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'>Front row: Ms. <span class=SpellE>Frei</span> and Ms. Ibanez/<span class=SpellE>Juvena</span> (2nd and 3rd from left), Dr. <span class=SpellE>Johncock</span>/<span class=SpellE>Symrise</span> (4th from left) and Ms <span class=SpellE>Boulding</span>/Arch (very right).<o:p></o:p></span></p> <p class=MsoPlainText align=center style='text-align:center'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p> <p class=MsoPlainText align=center style='text-align:center'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p> <p class=MsoPlainText align=center style='text-align:center'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-fareast-language:DE;mso-no-proof:yes'><img border=0 width=515 height=756 id="_x0000_i1036" src="news-Dateien/Certificate.jpg"></span></b><b style='mso-bidi-font-weight: normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p></o:p></span></b></p> <p class=MsoPlainText><b style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoPlainText><b style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoPlainText><b style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoPlainText><b style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoPlainText><b style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoPlainText><b style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'>23<sup>th</sup> March 2009 - &quot;Leaving Ball&quot; of the Institute of Pharmacy terminated<o:p></o:p></span></b></p> <p class=MsoPlainText><span lang=EN-US style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p> <p class=MsoPlainText><span lang=EN-US style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-ansi-language:EN-US'>In July 2008 (summer term semester) and February 2010 (winter term semester) there was no leaving ball because of too low interest of the students in their final term to participate, despite the availability of funding to co-sponsor the ball. Due to this lack of interest, therefore for the time being no leaving balls will be organized. Prof. Müller dropped his role as university patron of the ball.<o:p></o:p></span></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span lang=EN-US style='font-size:13.5pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span lang=EN-US style='font-size:13.5pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-US'>17<sup>th</sup> December 2008: <a href="http://www.muller-berlin.com/inno_newsletter.pdf"><span class=SpellE>Innovationspreis</span>-Newsletter 2008</a><o:p></o:p></span></b></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-US'>5<sup>th</sup> December 2008:<span style='mso-spacerun:yes'>    </span><span class=SpellE>Preise</span> <span class=SpellE>für</span> Innovation <span class=SpellE>vergeben</span>!<o:p></o:p></span></b></p> <p class=MsoNormal><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'> Innovation Awards of the Counties of Berlin-Brandenburg 2008 <o:p></o:p></span></p> <p class=MsoNormal><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p> <p class=MsoNormal><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'>Each year Berlin and Brandenburg recognize innovation in their counties by the  Innovation Award , given to companies or individuals. In general, there are about 150 applications each year, and about 4 awards are granted. In 2008, the  <span class=SpellE>nanodiamonds</span> were selected for the Innovation Award, a joint development by <span class=SpellE>PharmaSol</span> GmbH/Dr. C. Keck together with Prof. R. Müller/Free University of Berlin and the company P.W. <span class=SpellE>Beyvers</span> in Berlin. Other awardees in 2008 were e.g. Siemens AG for the development of a new gas turbine and the <span class=SpellE>Charité</span> hospital in Berlin (Prof. Speck) for a new therapeutic approach.<o:p></o:p></span></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-no-proof:yes'><img border=0 width=459 height=344 id="_x0000_i1035" src="news-Dateien/inno4.jpg"></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p></o:p></span></p> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Innovationspreis 2008 Berlin/Brandenburg<b><o:p></o:p></b></span></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span style='font-size: 10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal align=center style='text-align:center'><span style='mso-no-proof:yes'><img border=0 width=604 height=454 id="_x0000_i1034" src="news-Dateien/inno1.jpg"></span></p> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Preisübergabe: Mitte Dr. Keck und Prof. R.H. Müller, dann Senator Wolf/Berlin <o:p></o:p></span></p> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>und Wirtschaftsminister Junghanns/Brandenburg (von rechts nach links)<o:p></o:p></span></p> <p class=MsoNormal align=center style='margin-bottom:13.5pt;text-align:center'><b><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal align=center style='text-align:center'><span style='mso-no-proof:yes'><img border=0 width=496 height=374 id="_x0000_i1033" src="news-Dateien/inno2.jpg"></span></p> <p class=MsoPlainText align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Preisträger von rechts: Dr. R. Weigl als Vertreter der Firma P.W. <span class=SpellE>Beyvers</span>, <o:p></o:p></span></p> <p class=MsoPlainText align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Frau Dr. C. Keck/<span class=SpellE>PharmaSol</span> GmbH und Prof. R.H. Müller<o:p></o:p></span></p> <p class=MsoPlainText align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoNormal align=center style='text-align:center'><o:p>&nbsp;</o:p></p> <p class=MsoNormal align=center style='text-align:center'><span style='mso-no-proof:yes'><img border=0 width=330 height=344 id="_x0000_i1032" src="news-Dateien/inno3.jpg"></span></p> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Dr. Cornelia Keck und Prof. Rainer H. Müller<o:p></o:p></span></p> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>mit Innovationspreis<o:p></o:p></span></p> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Berliner Morgenpost: <a href="http://www.morgenpost.de/printarchiv/wirtschaft/article993141/Wirtschaft_und_Wissenschaft_vereint.html">06.12.2008</a><span style='mso-spacerun:yes'>     </span><a href="http://www.morgenpost.de/printarchiv/berlin/article993692/Preise_fuer_Innovationen_vergeben.html">07.12.2008</a><span style='mso-spacerun:yes'>     </span><a href="http://www.muller-berlin.com/inno_bemopo.jpg">Scan</a><o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Der Tagesspiegel: <a href="http://www.tagesspiegel.de/zeitung/Sonderthemen;art893,2677805">06.12.2008</a><span style='mso-spacerun:yes'>     </span><a href="http://www.muller-berlin.com/inno_dta.jpg">Scan</a><o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Märkische Allgemeine: <a href="http://www.muller-berlin.com/inno_ma.jpg">Scan</a><o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Rhein Zeitung: </span><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><a href="http://www.muller-berlin.com/inno_rz.jpg"><span lang=DE style='mso-ansi-language:DE'>Scan</span></a></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p></o:p></span></p> <p class=MsoNormal align=center style='text-align:center'><o:p>&nbsp;</o:p></p> <p class=MsoNormal align=center style='text-align:center'><o:p>&nbsp;</o:p></p> <p class=MsoNormal style='margin-bottom:13.5pt'><span style='font-size:10.0pt; font-family:"Verdana","sans-serif";mso-bidi-font-weight:bold'>Video: <a href="http://www.innovationspreis-bb.de/index.php?option=com_content&amp;task=view&amp;id=173&amp;Itemid=1">Nanodiamanten für die Haut  Smart Crystals®</a><o:p></o:p></span></p> <p class=MsoNormal align=center style='margin-bottom:13.5pt;text-align:center'><b><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoPlainText><b style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'>November 2008:<o:p></o:p></span></b></p> <p class=MsoPlainText><span lang=EN-US style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-ansi-language:EN-US'>NLC in the press, cosmetic journal &quot;<span class=SpellE>Profi</span> <span class=SpellE>Kosmetik</span>&quot;, interview Dr. <span class=SpellE>Rimpler</span>, CSO of Dr. <span class=SpellE>Rimpler</span> GmbH/Germany, <span class=GramE>the</span> company which placed the first cosmetic products with NLC on the market in 2005. (Article in German)<o:p></o:p></span></p> <p class=MsoPlainText><b style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoPlainText><span lang=EN-US style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-ansi-language:EN-US'><a href="http://userpage.fu-berlin.de/%7Empharma2/Download/news/profikosmetik.pdf">click here for full article</a><o:p></o:p></span></p> <p class=MsoPlainText><b style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoPlainText><b style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoPlainText><b style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoPlainText><b style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoPlainText><b style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoPlainText><b style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'>13th November 2008:<span style='mso-spacerun:yes'>   </span>Prof. Müller nominated for the Innovation Award Berlin-Brandenburg 2008 (<span class=SpellE>Innovationspreis</span> Berlin-Brandenburg 2008)<o:p></o:p></span></b></p> <p class=MsoPlainText><span lang=EN-US style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p> <p class=MsoPlainText><span lang=EN-US style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-ansi-language:EN-US'>It is the 25th anniversary of the Innovation Award Berlin-Brandenburg. In a press conference the 7 nominees for the Award 2008 were announced in the Liebermann Building in Berlin on 13 November 2008. The final 4 <o:p></o:p></span></p> <p class=MsoPlainText><span class=GramE><span lang=EN-US style='font-size: 10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language:EN-US'>winners</span></span><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'> will be presented to the public during the official award ceremony on Friday 5 December 2008. Since its introduction about 110 awards have been given, promoting the future developments of these <o:p></o:p></span></p> <p class=MsoPlainText><span class=GramE><span lang=EN-US style='font-size: 10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language:EN-US'>innovations</span></span><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'> and the companies. The research consortium Dr. C. Keck/<span class=SpellE>PharmaSol</span> GmbH, D. <span class=SpellE>Karlowswki</span>/P.M. <span class=SpellE>Beyvers</span> GmbH and Prof. Müller were nominated with the innovation &quot;<span class=SpellE>Nanodiamonds</span>&quot; (<span class=SpellE>Nanodiamanten</span>) for <o:p></o:p></span></p> <p class=MsoPlainText><span class=GramE><span lang=EN-US style='font-size: 10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language:EN-US'>improved</span></span><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'> delivery of cosmetic actives and pharmaceutical drugs. Another area of application <span class=GramE>are</span> nutritional supplements. It is the second time that Prof. Müller was nominated, in 2006 he was nominated for the lipid <o:p></o:p></span></p> <p class=MsoPlainText><span class=SpellE><span class=GramE><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-US'>nanoparticle</span></span></span><span lang=EN-US style='font-size: 10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language:EN-US'> NLC technology together with the Berlin company <span class=SpellE>Chemisches</span> <span class=SpellE>Laboratorium</span> Dr. Richter (CLR) GmbH.<o:p></o:p></span></p> <p class=MsoPlainText><span lang=EN-US style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p> <p class=MsoPlainText><span lang=EN-US style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p> <p class=MsoPlainText align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-fareast-language: DE;mso-no-proof:yes'><img border=0 width=652 height=454 id="_x0000_i1031" src="news-Dateien/innovation01.JPG"></span><span lang=EN-US style='font-size: 10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language:EN-US'><o:p></o:p></span></p> <p class=MsoPlainText align=center style='text-align:center'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'>Picture of the nominees of Innovation award 2008 in front of the Liebermann Building/<span class=SpellE>Pariser</span> <span class=SpellE>Platz</span> in Berlin<o:p></o:p></span></p> <p class=MsoPlainText align=center style='text-align:center'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p> <p class=MsoPlainText><span lang=EN-US style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p> <p class=MsoPlainText align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-fareast-language: DE;mso-no-proof:yes'><img border=0 width=285 height=380 id="_x0000_i1030" src="news-Dateien/innovation02.JPG"></span><span lang=EN-US style='font-size: 10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language:EN-US'><o:p></o:p></span></p> <p class=MsoPlainText align=center style='text-align:center'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'>Prof. Müller as representative of the nominated research consortium<o:p></o:p></span></p> <p class=MsoPlainText align=center style='text-align:center'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-US'>Dr. C. Keck/<span class=SpellE>PharmaSol</span> GmbH, D. <span class=SpellE>Karlowswki</span>/P.M. <span class=SpellE>Beyvers</span> GmbH and Prof. Müller<o:p></o:p></span></p> <p class=MsoPlainText><span lang=EN-US style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b style='mso-bidi-font-weight: normal'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Press <span class=SpellE>release</span> Freie Universität Berlin 13 November 2008:<o:p></o:p></span></b></p> <p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto; mso-outline-level:1'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-font-kerning:18.0pt;mso-bidi-font-weight:bold'>Professor Rainer H. Müller für Innovationspreis Berlin-Brandenburg 2008 nominiert </span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-bidi-font-weight: bold'>Pharmazeut der Freien Universität Berlin entwickelt ultrafeine Wirkstoffkristalle <o:p></o:p></span></p> <p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Nr. 361/2008 vom 13.11.2008 <o:p></o:p></span></p> <p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-bidi-font-weight: bold'>Rainer H. Müller, Professor für Pharmazeutische Technologie am Institut für Pharmazie der Freien Universität Berlin, ist für den Innovationspreis Berlin-Brandenburg 2008 nominiert worden. Die gemeinsame Bewerbung des Wissenschaftlers mit den Unternehmen <span class=SpellE>PharmaSol</span> GmbH und P.M. <span class=SpellE>Beyvers</span> GmbH wurde unter 142 Bewerbungen ausgewählt. Die Auszeichnung wird im Dezember 2008 an maximal fünf Preisträger vergeben und ist mit jeweils 10.000 Euro dotiert. </span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p></o:p></span></p> <p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Nominiert wurde Professor Rainer H. Müller für die Entwicklung sogenannter Nanodiamanten. Diese ultrafeinen Kristalle erhöhen die Löslichkeit und die biologische Aktivität schwer löslicher Natur- und Arzneistoffe. Dies gelingt, indem Partikel eines Wirkstoffes von Makrogröße in die Nanodimension verkleinert werden (ein Nanometer ist ein Milliardstel Meter). Durch diese Verkleinerung erhalten die Substanzen neue physikalische Eigenschaften, etwa eine größere Oberfläche und eine bessere Löslichkeit. Die Technologie, um diese Nanodiamanten zu erzeugen, entwickelte Professor Rainer H. Müller auf der Basis der <span class=SpellE>Hochdruckhomogenisation</span>, bekannt von homogenisierten Lebensmitteln. Für die Produktion von Nanokristallen ist dabei ein hoher <span class=SpellE>Homogenisationsdruck</span> von bis zu 1.500 bar erforderlich (zum Vergleich: ein Autoreifen hat etwa zwei bar). Erste Studien mit dem Kosmetikwirkstoff Rutin in einer Hautcreme ergaben, dass Rutin-Nanokristalle eine 500-fach höhere Bioaktivität besitzen als das herkömmliche wasserlösliche <span class=SpellE>Rutinglycosid</span>.<o:p></o:p></span></p> <p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Der Innovationspreis wird von den Ländern Berlin und Brandenburg gemeinsam mit der Wirtschaft der Hauptstadtregion in Public-Private-<span class=SpellE>Partnership</span> vergeben. Die Auszeichnung soll herausragende Innovationen würdigen und zielt auf eine Vernetzung von Forschung, Entwicklung und Unternehmen. Über Nominierungen und Preisträger entscheidet eine unabhängige Jury unter Vorsitz von Professor Manfred <span class=SpellE>Hennecke</span>, Präsident der Bundesanstalt für Materialforschung und -prüfung.<o:p></o:p></span></p> <p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto; mso-outline-level:2'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-bidi-font-weight:bold'>Weitere Informationen:<o:p></o:p></span></p> <p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Professor Dr. Rainer H. Müller, Freie Universität Berlin, Institut für Pharmazie, Pharmazeutische Technologie, Telefon: 030 / 838-50678 , Telefax: 030 / 838-50701 , E-Mail: <a href="mailto:mpharma@zedat.fu-berlin.de">mpharma@zedat.fu-berlin.de</a><o:p></o:p></span></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span style='font-size: 10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span style='font-size: 10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span style='font-size: 10.0pt;font-family:"Verdana","sans-serif"'>11<sup>th</sup> June 2008: Rainer Müller und Monika Schäfer-<span class=SpellE>Korting</span> gewannen den Transferpreis <span class=SpellE>WissensWerte</span><o:p></o:p></span></b></p> <p class=MsoNormal align=center style='margin-bottom:13.5pt;text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-bidi-font-weight: bold'><a href="http://www.muller-berlin.com/tagesspiegel.jpg">Tagesspiegel</a><o:p></o:p></span></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span style='font-size: 10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span style='font-size: 10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span style='font-size: 10.0pt;font-family:"Verdana","sans-serif"'>PZ 25/2008:<o:p></o:p></span></b></p> <p class=MsoNormal align=center style='margin-bottom:13.5pt;text-align:center'><b style='mso-bidi-font-weight:normal'><span style='font-size:13.5pt;font-family: "Verdana","sans-serif";mso-no-proof:yes'><img border=0 width=447 height=952 id="_x0000_i1029" src="news-Dateien/PZ.JPG"></span></b><b><span style='font-size:13.5pt;font-family:"Verdana","sans-serif"'><o:p></o:p></span></b></p> <p class=MsoNormal align=center style='margin-bottom:13.5pt;text-align:center'><b><span style='font-size:13.5pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal align=center style='margin-bottom:13.5pt;text-align:center'><b><span style='font-size:13.5pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b><span style='font-size: 10.0pt;font-family:"Verdana","sans-serif"'>DAZ 25/2008:<o:p></o:p></span></b></p> <p class=MsoNormal align=center style='text-align:center'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-no-proof:yes'><img border=0 width=605 height=797 id="_x0000_i1028" src="news-Dateien/DAZ.JPG"></span></b><b style='mso-bidi-font-weight: normal'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p></o:p></span></b></p> <p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>1<sup>st</sup> June 2008 : Prof. Speiser: Vater der Pharma-Nanotechnologie an FU ausgezeichnet<o:p></o:p></span></b></p> <p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal align=center style='text-align:center'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;font-family: "Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal align=center style='text-align:center'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-no-proof:yes'><img border=0 width=227 height=303 id="_x0000_i1027" src="news-Dateien/speiserewps.jpg"></span></b><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;font-family: "Verdana","sans-serif"'><o:p></o:p></span></b></p> <p class=MsoNormal align=center style='text-align:center'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;font-family: "Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Am 30./31. Mai fand im Henry-Ford Bau der FU der European Workshop on <span class=SpellE>Particulate</span> Systems (EWPS) statt. EWPS ist das Nano-Meeting führender europäischer pharmazeutischer Institute in der Nanotechnologie, an der FU organisiert von Prof. R. H. Müller und Dr. C. M. Keck, FU-Pharmazie (<a href="http://www.muller-berlin.com/">www.muller-berlin.com</a>). Bei der Eröffnungsfeier zum zehnjährigen Jubiläum von EWPS wurde der Schweizer Professor Dr. Peter P. Speiser mit dem  <span class=SpellE>Lifetime</span> <span class=SpellE>Achievement</span> Award <span class=SpellE>for</span> <span class=SpellE>Pioneering</span> Work on Nanosystems ausgezeichnet. Die Laudatio hielt Prof. Dr. R. <span class=SpellE>Gurny</span> vom Pharmazeutischen Institut in Genf.<o:p></o:p></span></p> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-no-proof:yes'><img border=0 width=402 height=303 id="_x0000_i1026" src="news-Dateien/mullerundspeiser.jpg"></span><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'><o:p></o:p></span></p> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><o:p>&nbsp;</o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Nanopartikel werden in der Pharmazie vielfältig eingesetzt, vom gezielten Transport der Arzneistoffe zum <span class=SpellE>Wirkort</span> ( Nanotaxis ) bis hin zur Gentherapie. Prof. Speiser hat in der Promotionsarbeit seines Doktoranden Dr. <span class=SpellE>Birrenbach</span> an der ETH Zürich 1973 zum ersten Mal pharmazeutisch den Begriff  Nanokapsel (<span class=SpellE>nanocapsule</span>) benutzt, was als der Beginn der pharmazeutischen Nanotechnologie zur kontrollierten Wirkstoffapplikation gesehen werden kann. Viele weitere Arbeiten folgten bis zu seiner Pensionierung mit 72 Jahren. Der heute 88 jährige Prof. Speiser eröffnete offiziell EWPS mit einem <span class=SpellE>brillianten</span> Überblick zur Situation der pharmazeutischen Nanotechnologie.<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Rund 60 Wissenschaftler aus 8 europäischen Ländern nahmen am <span class=SpellE>Kongreß</span> teil, über 40 wissenschaftliche Beiträge wurden präsentiert (<a href="http://www.ewps.org/">www.ewps.org</a>). Ausgewählte Vorträge werden in einem Sonderheft des International Journal <span class=SpellE>of</span> <span class=SpellE>Pharmaceutics</span> publiziert werden. Für seinen essentiellen Beitrag zur Etablierung von EWPS während der letzten zehn Jahre wurde Prof. Sandy Florence von London mit dem  <span class=SpellE>Founders</span> Award <span class=SpellE>for</span> <span class=SpellE>important</span> <span class=SpellE>contributions</span> <span class=SpellE>to</span> <span class=SpellE>the</span> <span class=SpellE>development</span> <span class=SpellE>of</span> EWPS ausgezeichnet. Das nächste EWPS Meeting findet im Mai 2010 in Paris statt. Da EWPS in Berlin gegründet wurde, findet die Zwanzigjahrfeier  schon jetzt von den <span class=SpellE>Organisatoeren</span> festgelegt  dann wieder an der FU Berlin statt.<o:p></o:p></span></p> <p class=MsoNormal><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>Für Nachfragen steht zur Verfügung: Prof. Dr. Rainer H. Müller, Institut für Pharmazie, Kelchstr. </span><span lang=EN-GB style='font-size:10.0pt; font-family:"Verdana","sans-serif";mso-ansi-language:EN-GB'>31, Tel. =30  838 506 78, Fax: 030  838 506 16, mail: </span><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'><a href="mailto:nanoteam@gmx.com"><span lang=EN-GB style='mso-ansi-language:EN-GB'>nanoteam@gmx.com</span></a></span><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'>, homepages: </span><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'><a href="http://www.muller-berlin.com/"><span lang=EN-GB style='mso-ansi-language:EN-GB'>www.muller-berlin.com</span></a></span><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'>, </span><span style='font-size:10.0pt;font-family: "Verdana","sans-serif"'><a href="http://www.ewps.org/"><span lang=EN-GB style='mso-ansi-language:EN-GB'>www.ewps.org</span></a></span><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'><o:p></o:p></span></p> <p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-US'><o:p>&nbsp;</o:p></span></b></p> <p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'>30  31 May 2008 : European Workshop on Particulate Systems (EWPS)<o:p></o:p></span></b></p> <p class=MsoNormal><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'>At the end of May Professor Müller and Dr. Keck organize EWPS in <st1:state w:st="on"><st1:place w:st="on">Berlin</st1:state></st1:place>, this event will celebrate  one decade EWPS . EWPS is the research network of leading institutes of pharmaceutical technology and <span class=SpellE>biopharmaceutics</span> in different countries of <st1:place w:st="on">Europe</st1:place>. EWPS focuses on nanotechnology, that means nanocarriers which deliver drugs in an optimized way, ideally transport drugs to their desired site of action (drug targeting). The meeting will be opened by Professor Dr. P.P. <span class=SpellE>Speiser</span> from <st1:country-region w:st="on"><st1:place w:st="on">Switzerland</st1:place></st1:country-region>, the father of polymeric pharmaceutical nanoparticles for drug delivery. Vice president Professor Dr. M. <span class=SpellE>Schäfer-Korting</span> will deliver a welcome address on behalf of the Free University of Berlin. The meeting is sponsored by the Free University of Berlin and the European Association of <span class=SpellE>Pharma</span> Biotechnology (EAPB) as academic sponsors and from pharmaceutical and cosmetic industry. The sponsoring companies are <span class=SpellE>Juvena</span> <st1:country-region w:st="on">Switzerland</st1:country-region>, <span class=SpellE>PharmaSol</span> GmbH <st1:state w:st="on">Berlin</st1:state> and <span class=SpellE>Soliqs</span>/Abbott Germany/US as platinum sponsors and <span class=SpellE>Brookwood</span>/Alabama in US and Dr. <span class=SpellE>Rimpler</span> GmbH/<span class=SpellE>Wedemark</span> in <st1:country-region w:st="on"><st1:place w:st="on">Germany</st1:place></st1:country-region> as gold sponsors.<o:p></o:p></span></p> <p class=MsoNormal style='margin-bottom:13.5pt'><b style='mso-bidi-font-weight: normal'><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></b></p> </td> </tr> <tr style='mso-yfti-irow:1'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'>1st February 2007 : NLC technology/<span class=SpellE>nanopearls</span> in the press </span></b><span lang=EN-GB style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-ansi-language:EN-GB'><br> The <span class=SpellE>nanolipid</span> carrier (NLC) technology developed by Prof. Rainer H. Müller has meanwhile been introduced to almost 20 cosmetic products on the cosmetic market. The first products were introduced by Dr. <span class=SpellE>Rimpler</span> GmbH/Germany. The cosmetic trade name of these lipid nanoparticles is <span class=SpellE>Nanopearls</span>. The cosmetic journal &quot;<span class=SpellE>Kosmetik</span> International&quot; published an interview and product information about NLC/<span class=SpellE>Nanopearls</span> in the issue January 2007. <o:p></o:p></span></p> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><a href="http://www.muller-berlin.com/Pics/seite1.jpg">Page 1</a>&nbsp;&nbsp;&nbsp;&nbsp;<a href="http://www.muller-berlin.com/Pics/seite2.jpg">Page 2</a>&nbsp;&nbsp;&nbsp;&nbsp;<a href="http://www.muller-berlin.com/Pics/seite3.jpg">Page 3</a>&nbsp;&nbsp;&nbsp;&nbsp; <o:p></o:p></span></p> <p class=MsoNormal style='margin-bottom:12.0pt'><o:p>&nbsp;</o:p></p> </td> </tr> <tr style='mso-yfti-irow:2'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'>5th January <span class=GramE>2007 :</span> Cooperation Dr. <span class=SpellE>Rimpler</span> GmbH and Prof. Müller/FU </span></b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'><br> The concept of lipid nanoparticles was developed by Prof. Müller and his research group. The <span class=SpellE>nanostructured</span> lipid carriers (NLC) were developed as second generation in 1999/2000. In lipid <span class=SpellE>nanoparticle</span> technology the same concept was followed as with the <span class=SpellE>liposomes</span>. They appeared first in cosmetic products (Dior, 1986) before they entered the pharmaceutical market. In cooperation with Dr. <span class=SpellE>Rimpler</span> the first NLC-based cosmetic product was realised in 2004 (product <span class=SpellE>Nanorepair</span>, cosmetic line &quot;Dr. <span class=SpellE>Rimpler</span> <span class=SpellE>Kosmetik</span>&quot;). In the year 2006 the next products followed in the cosmetic line &quot;Isabelle <span class=SpellE>Lancray</span>, <st1:city w:st="on"><st1:place w:st="on">Paris</st1:city></st1:place>&quot;. In 2006 the product developed by Dr. <span class=SpellE>Rimpler</span> based on Prof. <span class=SpellE>Müller's</span> NLC technology was awarded with the so-called &quot;Cosmetic Oscar&quot; for the &quot;most innovative cosmetic product of the year 2006&quot;. That means the year 2006 was very successful for Dr. <span class=SpellE>Rimpler</span>, this is especially nice because it is the 20 year anniversary of the Dr. <span class=SpellE>Rimpler</span> cosmetic line and the 60 year anniversary of the line &quot;Isabelle <span class=SpellE>Lancray</span>&quot; </span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><a href="http://www.muller-berlin.com/Download/news/news5107.pdf"><span lang=EN-GB style='mso-ansi-language:EN-GB'>(summary article in BEAUTY FORUM 12/2006)</span></a></span><span lang=EN-GB style='font-size:10.0pt; font-family:"Verdana","sans-serif";mso-ansi-language:EN-GB'>. </span><span lang=EN-GB style='mso-ansi-language:EN-GB'><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:3'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span style='font-size: 10.0pt;font-family:"Verdana","sans-serif"'>11th <span class=SpellE>December</span> <span class=GramE>2006 :</span> Prof. <span class=SpellE>Müller's</span> NLC <span class=SpellE>technology</span>: <span class=SpellE>triple</span> &quot;<span class=SpellE>Cosmetic</span> Oscar&quot; <span class=SpellE>winner</span></span></b><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><br> Parallel zur Nominierung für den Innovationspreis Berlin-Brandenburg erhielt die Nanolipid-Technologie im dritten Jahr hintereinander den jährlichen Innovationspreis des <a href="http://www.verlag-drriedel.de/de/frameset.php3">BSB Verlags Dr. Riedel/Hamburg</a>. Eine internationale Jury mit Vertretern wichtiger kosmetischer Firmen wählt in verschiedenen Kategorien den Innovationspreis. Die Nanolipid-Technologie erhielt 2004 den Preis für  den innovativsten kosmetischen Rohstoff , im Jahr 2005 die Anerkennung für das  beste wissenschaftliche Fortbildungsseminar und kürzlich den Preis für  das innovativste kosmetische Produkt des Jahres 2006 . Aufgrund des Designs des Preises wird er in kosmetischen Fachkreisen als der  Kosmetik-Oscar bezeichnet. Die NLC-Technologie ist somit  3-facher Oscar-Gewinner in drei aufeinanderfolgenden Jahren. </span></p> </td> </tr> <tr style='mso-yfti-irow:4'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span style='font-size: 10.0pt;font-family:"Verdana","sans-serif"'>11th <span class=SpellE>December</span> <span class=GramE>2006 :</span> Innovation <span class=SpellE>prize</span> <span class=SpellE>nomination</span> Berlin-Brandenburg</span></b><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><br> Nanostrukturierte Lipid-<span class=SpellE>Carrier</span> (NLC) sind winzige Nanopartikel mit einem Durchmesser kleiner als <span class=SpellE>einhunderttausendstel</span> Millimeter. Sie bestehen aus verträglichen pflanzlichen festen Lipiden, z. B. dem hautpflegenden <span class=SpellE>Carnauba-Wax</span> und Ölen reich an Omega-3 und Omega-6 ungesättigten Fettsäuren. Diese  Nanolipid-Partikel transportieren als  Nanotaxis kosmetische und pharmazeutische Wirkstoffe besser in die Haut. Nanolipid-Kosmetika haben daher eine verbesserte Wirksamkeit.<br> Die  NanoLipid-Partikel als Transport- und Schutzsystem für Wirkstoffe wurden von 146 Einreichungen unter die 7 Nominierten für den Innovationspreis Berlin-Brandenburg 2006 ausgewählt. Die Entwicklung war ein Gemeinschaftsprojekt der Firma Chemisches Laboratorium Dr. Kurt Richter GmbH (CLR) und Herrn Prof. Dr. R. H. Müller von der Freien Universität Berlin.<br> Die Nominierten finden Sie <a href="http://www.muller-berlin.com/Download/news/innoberlin.htm">hier</a>. </span></p> </td> </tr> <tr style='mso-yfti-irow:5'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'>NLC technology entered the cosmetic market</span></b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'> In the nineties the first generation of lipid nanoparticles, the SLN (solid lipid nanoparticles) was developed by the research group of Prof. Müller, the second generation followed at the turn of the <span class=SpellE>millenium</span>, the NLC (<span class=SpellE>nanostructured</span> lipid carriers). The NLC have advantages compared to the first generation, e. g. improved loading capacity for actives.<br> <br> The first two cosmetic products based on the NLC technology were introduced to the market by the company Dr. <span class=SpellE>Rimpler</span> GmbH in <span class=SpellE>Wedemark</span>/Hannover in <st1:country-region w:st="on"><st1:place w:st="on">Germany</st1:place></st1:country-region>. The products <span class=SpellE>NanoRepair</span> Q10 <span class=SpellE>Creme</span> and <span class=SpellE>NanoRepair</span> Q10 Serum were introduced to the market during the cosmetic fair &quot;Beauty&quot; in Munich on 29/30 October 2005. More details about the technology and the products can be found in an </span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><a href="http://www.muller-berlin.com/nlc2.pdf"><span lang=EN-GB style='mso-ansi-language:EN-GB'>article</span></a></span><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'> in <span class=SpellE>EuroCosmetics</span> 11/12 2005, page 28ff. Information about the company can be obtained from </span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><a href="http://www.rimpler.de/"><span lang=EN-GB style='mso-ansi-language:EN-GB'>www.rimpler.de</span></a></span><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'>. </span><span lang=EN-GB style='mso-ansi-language: EN-GB'><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:6'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'>PhD student <span class=SpellE>Franziska</span> Rank - no. 58 - graduated</span></b><span lang=EN-GB style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-ansi-language:EN-GB'><br> On Wednesday, 7 December 2005, the 58th PhD student in Prof. <span class=SpellE>Müller's</span> research group graduated: Dr. <span class=SpellE>Franziska</span> Rank. She obtained her PhD in the area quality management (QM), the title of the thesis was: <br> &quot;Integrated Management System (IMS) for Quality <span class=SpellE>Assuarance</span> in Pharmaceutical Production - Analysis and Model Development&quot;. <br> <br> The research was a joint project between Schering AG in <st1:state w:st="on">Berlin</st1:state> and the pharmacy <st1:placename w:st="on">department/Free</st1:placename> <st1:placetype w:st="on">University</st1:placetype> of <st1:state w:st="on"><st1:place w:st="on">Berlin</st1:state></st1:place>. The many joint research PhD projects going on between the pharmacy department and companies demonstrate that not only basic research but also applied research is being performed in <st1:state w:st="on"><st1:place w:st="on">Berlin</st1:state></st1:place>.<o:p></o:p></span></p> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-no-proof:yes'><img border=0 width=640 height=480 id="_x0000_i1025" src="news-Dateien/disputationfranziska.jpg"></span><span style='font-size: 10.0pt;font-family:"Verdana","sans-serif"'><o:p></o:p></span></p> <p class=MsoNormal style='margin-bottom:12.0pt'><o:p>&nbsp;</o:p></p> </td> </tr> <tr style='mso-yfti-irow:7'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'>16th July <span class=GramE>2005 :</span> 3rd Leaving Ball of pharmacy</span></b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'><br> The 3rd leaving ball will again be again be organised in the five star hotel <span class=SpellE>Steigenberger</span>. Patrons are again Prof. Müller / Free University and Alexander <span class=SpellE>Djamal</span> / Deutsche <span class=SpellE>Ärztefinanz</span>. As before main financial sponsors are Deutsche <span class=SpellE>Ärztefinanz</span>, <span class=SpellE>SChering</span> AG, <span class=SpellE>hexal</span>/<span class=SpellE>ratiopharm</span> and <span class=SpellE>PharmaSol</span> GmbH. A ticket is EUR 55,-, and includes all-inclusive buffet and drinks from 19.00 - 23.00 o'clock and also a free tombola ticket. </span><span class=SpellE><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>For</span></span><span style='font-size: 10.0pt;font-family:"Verdana","sans-serif"'> <span class=SpellE>purchase</span> <span class=SpellE>please</span> <span class=SpellE>click</span> <a href="http://www.muller-berlin.com/abs.htm"><span class=SpellE>here</span></a>. </span></p> </td> </tr> <tr style='mso-yfti-irow:8'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'>12 - 17 June 2005 - <span class=SpellE>PharmSciFair</span> <span class=GramE>and EAPB :</span></span></b><span lang=EN-GB style='font-size: 10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language:EN-GB'><br> The first pharmaceutical <span class=SpellE>Sciencefair</span> (<span class=SpellE>PharmSciFair</span>) takes place in Nice this year. It was initiated and mainly organised by the European Federation of Pharmaceutical Scientist (EFUPS). The concept of the <span class=SpellE>PharmSciFair</span> is that a number of different pharmaceutical congresses take place in parallel. Buy one ticket and get access to many conferences. Prof. Müller is general secretary of the European Association of <span class=SpellE>Pharmabiotechnology</span> (EAPB). EAPB will organize its 2nd <span class=SpellE>PharmaBioTech</span> Europe in Nice. Prof. Müller is one of the chairmen of <span class=SpellE><span class=GramE>PharmaBioTech</span></span><span class=GramE>,</span> in addition the EAPB office in <st1:state w:st="on"><st1:place w:st="on">Berlin</st1:state></st1:place> organizes an EAPB booth in Nice. EAPB has its official office in the department of Pharmaceutical Technology/Free University of Berlin. </span><span lang=EN-GB style='mso-ansi-language:EN-GB'><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:9'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'>1-3 June 2005 - Chair in <st1:city w:st="on">Manchester</st1:city> <span class=GramE>/ update :</span></span></b><span lang=EN-GB style='font-size: 10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language:EN-GB'><br> By letter dated 30.March 2005 Prof. Müller received the offer of a chair in Biopharmaceutics and Biotechnology at the pharmaceutical department of the <st1:placetype w:st="on"><st1:place w:st="on">university</st1:placetype> of <st1:placename w:st="on">Manchester</st1:placename></st1:place>. Prof. Müller visited <st1:city w:st="on">Manchester</st1:city> university for two days to discuss the offer by <st1:city w:st="on"><st1:place w:st="on">Manchester</st1:city></st1:place> university in detail, i.e. the total of research money, equipment, <span class=SpellE>labspace</span> and new permanent staff for the research group. In addition, a new research concept was developed together with Prof. Gifford, head of school of pharmacy, and Prof. D. Gordon, vice president of <st1:placename w:st="on">Manchester</st1:placename> <st1:placetype w:st="on">University</st1:placetype>, which should give <st1:city w:st="on"><st1:place w:st="on">Manchester</st1:city></st1:place> a unique position within the British pharmacy departments. Another equally important point was the curriculum of the pharmacy students. A concept was discussed with Prof. Gifford and <st1:place w:st="on">Stirling</st1:place>, dean of education, to revise the curriculum, aim is <span class=GramE>to</span> adept the content to the present needs of community pharmacy but also pharmaceutical companies. Especially education should be optimized considering industrial pharmaceutical needs to further increase the number of pharmacists in pharmaceutical industries and thus potentially compensating job losses in community in pharmacies due to structural changes in the health systems (reduction of standing for health systems). </span><span lang=EN-GB style='mso-ansi-language:EN-GB'><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:10'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'>14 April 2005 - Research cooperation Prof. Müller and CLR GmbH<span class=GramE>/Berlin :</span></span></b><span lang=EN-GB style='font-size: 10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language:EN-GB'><br> A research cooperation was agreed between Prof. Müller and CLR Dr. Kurt Richter <span class=SpellE>Laboratorien</span> GmbH (CLR). The cooperation concerns development of cosmetic <span class=SpellE>excipients</span> based on <span class=SpellE>nanostructured</span> lipid carriers (NLC). One the two main research areas of Prof. Müller. One aim of the cooperation is to develop special large scale production lines to even process chemically sensitive cosmetic actives. Apart from financially supporting the research by Prof. Müller, CLR provides access to its industrial facilities to perform basic research. </span><span lang=EN-GB style='mso-ansi-language:EN-GB'><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:11'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'>5 April 2005 - <span class=SpellE>Nano</span> for life - Application, <span class=GramE>Consortium SLN :</span></span></b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'><br> The German Ministry of Research (<span class=SpellE>BmBF</span>) decided to promote nanotechnology in <st1:place w:st="on"><st1:country-region w:st="on">Germany</st1:country-region></st1:place> with a special support <span class=SpellE>programm</span>, <span class=SpellE>Nano</span> for Life. With almost 30 million Euros research consortia are sponsored developing <span class=SpellE>nanoparticle</span> products in life sciences (pharmacy, medicine). The consortia should be industry driven, that means there should be academic partners, but the <span class=SpellE>emphesis</span> are a mixture of small/medium sized companies with larger companies. Innovative ideas should be developed to be placed as products on the market. Up to 50% of the costs of companies will be reimbursed in this <span class=SpellE>programm<span class=GramE>,universities</span></span> should receive 100% reimbursement of their costs. The research group of Prof. Müller is part of a consortium to develop products based on lipid nanoparticles. The consortium consists of four companies plus the research group of <span class=SpellE>Porf</span>. </span><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>Müller. </span></p> </td> </tr> <tr style='mso-yfti-irow:12'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'>3 April 2005 - Offer of chair in Manchester to Prof. Müller</span></b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'><br> The university of Manchester offered to Prof. Müller the chair in &quot;Biopharmaceutics and Biotechnology&quot; at the Pharmacy department. The <st1:placetype w:st="on"><st1:place w:st="on">university</st1:placetype> of <st1:placename w:st="on">Manchester</st1:placename></st1:place> was re-founded last year by uniting the two previous universities. <span class=SpellE>Offical</span> opening of the new university took place in the presence of her majesty the queen. Strategic target is to establish <st1:city w:st="on"><st1:place w:st="on">Manchester</st1:city></st1:place> university as <span class=SpellE>aleading</span> university, the development are that the department of pharmacy should be one of the ten leading pharmacy institutes in the world. The faculty of medicine is currently appointing a number of professors to reach this development target. Part of the concept is also to provide the pharmacy with a new building The first research groups will move in within the next months, the building will be completed in <span class=SpellE>june</span>/<span class=SpellE>july</span> 2006 with total costs of about 16 million pound sterling (<span class=SpellE>appr</span>. </span><span style='font-size:10.0pt; font-family:"Verdana","sans-serif"'>24 <span class=SpellE>million</span> Euro). <span class=SpellE>Anticipated</span> <span class=SpellE>starting</span> <span class=SpellE>is</span> 1st <span class=SpellE>september</span> 2005. </span></p> </td> </tr> <tr style='mso-yfti-irow:13'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'>March <span class=GramE>2005 :</span> PCIE <st1:city w:st="on"><st1:place w:st="on">Paris</st1:city></st1:place> ESB Oskar for Prof. Müller :</span></b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'><br> At the PCIE (Gabi <span class=SpellE>fragen</span> <span class=SpellE>Konferenz</span> Name) Prof. Müller obtained the &quot;ESB-Oskar&quot; for the &quot;best international seminar in cosmetics&quot;. The topic of the seminar was &quot;Solid lipid nanoparticles (SLN<span class=GramE>)for</span> cosmetic use&quot;. The ESB-Oskar awards are yearly given by the company ESB Dr. Riedel <span class=SpellE>Verlag</span> /<st1:state w:st="on"><st1:place w:st="on">Hamburg</st1:state></st1:place>. The jury is composed of representatives of major international cosmetic companies (e.g. <span class=SpellE>Loreal</span>, Chanel, <span class=SpellE>Beiersdorff</span> etc.). It was the second ESB Oskar fro Prof. Müller, after having received the &quot;ESB-Oskar for the most innovative cosmetic <span class=SpellE>excepient</span>&quot; in 2004. </span><span lang=EN-GB style='mso-ansi-language:EN-GB'><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:14'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'>March <span class=GramE>2005 :</span> PCIE <st1:city w:st="on">Paris</st1:city> ESB Oskar for Dr. Sven <span class=SpellE>Gohla</span></span></b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'><br> At the PCIE in <st1:city w:st="on"><st1:place w:st="on">Paris</st1:city></st1:place> the &quot;ESB-Oskar for the most innovative cosmetic <span class=SpellE>exciepient</span>&quot; was awarded to Dr. Sven <span class=SpellE>Gohla</span>. Dr. Sven <span class=SpellE>Gohla</span> is head of formulation development at <span class=SpellE>Juvena</span> /<st1:country-region w:st="on"><st1:place w:st="on">Switzerland</st1:place></st1:country-region> (Vice President of Research and Development)<span class=GramE>,</span> at the same time Dr. <span class=SpellE>Gohla</span> is &quot;<span class=SpellE>Habilitant</span>&quot; in the research group of Prof. Müller. The Oskar <span class=SpellE>acknowloges</span> the development of a new concept for anti-aging of the skin. </span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>(RS Müller) </span></p> </td> </tr> <tr style='mso-yfti-irow:15'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'>5 February <span class=GramE>2005 :</span> 2nd &quot;Leaving ball&quot; of pharmacy students, 8th semester</span></b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'><br> The second leaving ball took place at the five star hotel <span class=SpellE>Steigenberger</span> in <st1:state w:st="on"><st1:place w:st="on">Berlin</st1:state></st1:place>. The patrons were Prof. Müller from the Free University of <st1:state w:st="on"><st1:place w:st="on">Berlin</st1:state></st1:place> and Alexander <span class=SpellE>Djamal</span> from the Deutsche <span class=SpellE>Ärztefinanz</span>. Members of the organisation team were mainly students from the 7th semester, two from the 8th semester. Sponsors were Deutsche <span class=SpellE>Ärztefinanz</span>, Schering AG, <span class=SpellE>hexel</span>/<span class=SpellE>ratiopharm</span> and <span class=SpellE>PharmaSol</span> GmbH/Berlin (in order of contribution). The ball attracted 200 guests. Among the guest were the Dean of the faculty Prof. <span class=SpellE>Hilger</span>, and the vice dean of the faculty Prof. <span class=SpellE>Schäfer-Korting</span> (faculty of Biology, Chemistry, <span class=GramE>Pharmacy</span>), the president Dr. <span class=SpellE>Bartezko</span> of the Apothekerkammer and the chairman Mr. Wagner of the <span class=SpellE>Apothekerverein</span> Berlin. It was a great <span class=SpellE>evening<span class=GramE>,the</span></span> last guests left the ball at around 5 o'clock in the morning. </span><span lang=EN-GB style='mso-ansi-language:EN-GB'><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:16'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><span class=SpellE><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'>Biofuture-Preis</span></b></span><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'> - 1.5 Mio. Euro</span></b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'><br> Dr. <span class=SpellE>Carsten</span> Rudolph, cooperating scientist of Prof. Müller, <span class=SpellE>reiceved</span> the <span class=SpellE>Biofuture</span> Award 2005 by the German Ministry of Research and Development (BMBF). This prize is annually awarded to promote young scientists at the beginning of their career to develop to level research. The award involves 1.5 Mio. Euro per scientist. Since 1998 more than 50 scientists have been awarded with the <span class=SpellE>Biofuture</span> Award.<br> Dr. <span class=SpellE>Rudoph</span> studied pharmacy at <st1:placename w:st="on">Marburg</st1:placename> <st1:placetype w:st="on">University</st1:placetype> and obtained his PhD in Pharmaceutical Biotechnology under the supervision of Prof. R. H. Müller in <st1:state w:st="on"><st1:place w:st="on">Berlin</st1:state></st1:place>. The PhD work was performed at the hospital at the <st1:placetype w:st="on"><st1:place w:st="on">University</st1:placetype> of <st1:placename w:st="on">Munich</st1:placename></st1:place>, co-supervised by Dr. J. <span class=SpellE>Rosenecker</span>. Dr. Rudolph continued his scientific work in <st1:city w:st="on"><st1:place w:st="on">Munich</st1:city></st1:place> and in 2003 he started to build up his own research group. At the same time he is &quot;<span class=SpellE>Habilitand</span>&quot; in the research group of Prof. Müller at the <st1:placetype w:st="on"><st1:place w:st="on">Institute</st1:placetype> of <st1:placename w:st="on">Pharmaceutical Sciences</st1:placename></st1:place>, Free University of Berlin.<br> <br> </span><span class=SpellE><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'>For</span></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'> <span class=SpellE>more</span> <span class=SpellE>information</span> <a href="http://www.muller-berlin.com/rudolph/rudolph.htm"><span class=SpellE>please</span> <span class=SpellE>click</span> <span class=SpellE>here</span></a>. </span></p> </td> </tr> <tr style='mso-yfti-irow:17'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal><b><span lang=EN-GB style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-ansi-language:EN-GB'>December 2004 - DFG network application brain targeting</span></b><span lang=EN-GB style='font-size:10.0pt; font-family:"Verdana","sans-serif";mso-ansi-language:EN-GB'><br> In December 2004 an application was filled to the German Research council (DFG) to establish a DFG <span class=SpellE>reseach</span> network of DFG-<span class=SpellE>Schwerpunktprogramm</span> &quot;Targeted drug delivery to the brain&quot;. This initiative was started by Prof. Müller in spring 2004. About 14 research groups from different disciplines all over <st1:country-region w:st="on"><st1:place w:st="on">Germany</st1:place></st1:country-region> worked together to establish a concept having a sufficient quality to be acceptable as a topic by the DFG &quot;<span class=SpellE>Schwerpunktprogramm</span>&quot;. At the end of the discussion process, about 30 research groups filed an application to improve delivery of drugs to the brain. The concept is based on the discovery by Prof. <span class=SpellE>Kreuter</span> / Frankfurt How to get nanoparticles across the blood brain barrier. Speaker of the group is Prof. Müller / Free University of Berlin, vice speaker is Prof. <span class=SpellE>Fahr</span>, pharmacy department at the <st1:placetype w:st="on"><st1:place w:st="on">university</st1:placetype> of <st1:placename w:st="on">Jena</st1:placename></st1:place>. </span><span lang=EN-GB style='mso-ansi-language:EN-GB'><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:18'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'><br style='mso-special-character:line-break'> <![if !supportLineBreakNewLine]><br style='mso-special-character:line-break'> <![endif]></span><span lang=EN-GB style='mso-ansi-language:EN-GB'><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:19'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'>AAPS in <st1:city w:st="on">Baltimore</st1:city> 7-11 November 2004</span></b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'><br> The American Association of Pharmaceutical Scientists (AAPS) has held its annual meeting in the convention centre in Baltimore/Maryland in <st1:place w:st="on"><st1:country-region w:st="on">USA</st1:country-region></st1:place>. It was a successful annual meeting with about 8,000 participants. The research group of Prof Müller was represented by 12 poster presentations and one invited lecture given by Prof Müller personally.<br> The title of the presentation was <b>Lipid nanoparticles for parenteral drug delivery</b>. <br> The following members of the research team were presented the meeting: <span class=SpellE>Torsten</span> Göppert, Norma <span class=SpellE>Hernández</span>-Trejo, <span class=SpellE>Conny</span> Keck, Jan <span class=SpellE>Möschwitzer</span> and <span class=SpellE>Eliana</span> <span class=SpellE>Souto</span>. <br> The AAPS meeting is the most important conference for the research team of Prof Müller, especially with regard to establishing research contacts to pharmaceutical industry. The scientific AAPS meeting is accompanied by a company <span class=GramE>exhibition,</span> about 1,000 companies are <span class=SpellE>regularily</span> present with a booth. </span><span lang=EN-GB style='mso-ansi-language:EN-GB'><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:20'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><st1:city w:st="on"><st1:place w:st="on"><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'>Baltimore</span></b></st1:place></st1:city><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'>: Meeting with Story Musgrave / NASA astronaut </span></b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'><br> Parallel to the AAPS annual conference in Baltimore, Prof Rainer H Müller and pharmacist <span class=SpellE>Conny</span> Keck met Dr Story Musgrave. <br> Dr Musgrave joined NASA as <span class=SpellE>scientistastronaut</span> in August 1967. Dr Musgrave is a veteran of six space flights, spending a total of 1,281 hours in space. His first flight was on space shuttle Challenger in 1983, followed by flights with the space shuttles Discovery and Endeavour. The Endeavour flight in 1993 was the first Hubble Space Telescope (HST) servicing and repair mission. During this 11-day flight, the HST was restored to its capabilities during a record of 5 space walks by the astronauts. Dr Musgrave performed 3 of these space walks. <br> Most recently, Dr Musgrave served aboard space shuttle <st1:city w:st="on"><st1:place w:st="on">Columbia</st1:city></st1:place>. The most interesting topic addressed by Dr Musgrave in the discussion was the <b>perfect separation</b> of 2-dimensional <span class=SpellE>electrophoretic</span> gels, one of the major research areas of Prof Müller. In space it is possible to separate proteins in an ideal manor. </span><span lang=EN-GB style='mso-ansi-language: EN-GB'><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:21'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'>Annual meeting of Controlled Release Society (CRS) from 20-26 July 2004 in Honolulu/Hawaii.</span></b><span lang=EN-GB style='font-size:10.0pt; font-family:"Verdana","sans-serif";mso-ansi-language:EN-GB'><br> The annual meeting of the Controlled Release Society (CRS) took place in <st1:city w:st="on"><st1:place w:st="on">Honolulu</st1:city></st1:place> this year. CRS is the largest society in America to deal with general issues of controlled release in various areas, that means pharmacy but also for example cosmetics, food and agriculture. <br> The research group of Prof Müller presented a total of 4 poster contributions to this meeting. PhD students of Prof Müller attending this meeting were <span class=SpellE>Conny</span> Keck, Boris Petri and Felix <span class=SpellE>Tröster</span>. <br> Apart from scientific highlights, of course <st1:city w:st="on">Honolulu</st1:city> had its striking features such as <st1:placename w:st="on"><st1:place w:st="on">Waikiki</st1:placename> <st1:placetype w:st="on">Beach</st1:placetype></st1:place>, a beautiful sand beach with nice palm trees and excellent cocktails in various bars located at the beach. Highly recommended, and attended, was the pub <b>The Mouse</b> having a happy hour from 4-8 p.m. All cocktails with the volume of 0.4 l (!) were served for prices ranging from 2.00 to 2.50 USD (equivalent to app 1.50¬ to 2.00 ¬ ). The Mouse was heavily frequented not only by the research team from <st1:state w:st="on"><st1:place w:st="on">Berlin</st1:state></st1:place> but also by other scientists. </span><span lang=EN-GB style='mso-ansi-language: EN-GB'><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:22'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><span class=GramE><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'>July ,</span></b></span><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'> 2004 - PhD student number 50 !</span></b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'><br> On Mr. Stefan Anger completed his PhD under the supervision of Prof. Müller. Mr. Anger was the PhD student number 50 concluding <span class=SpellE>succesfully</span> his thesis. The thesis was awarded with the best possible grade &quot;summa cum laude&quot;. The picture shows Prof. Müller handing over the traditional &quot;PhD present&quot; of the research group, <span class=SpellE>Galilea</span> thermometer. The spheres of the thermometer are indicating the respective <span class=GramE>temperature,</span> represent the nanoparticles, the major research topic of the group. </span><span lang=EN-GB style='mso-ansi-language: EN-GB'><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:23'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal style='margin-bottom:12.0pt'><b><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'>AAPS meeting in <st1:city w:st="on">Salt Lake City</st1:city> 26-30 October 2003</span></b><span lang=EN-GB style='font-size:10.0pt;font-family: "Verdana","sans-serif";mso-ansi-language:EN-GB'><br> The annual meeting of the American Association of Pharmaceutical Scientists (AAPS) in 2003 took place in <st1:city w:st="on"><st1:place w:st="on">Salt Lake City</st1:city>, <st1:state w:st="on">Utah</st1:state></st1:place>. <br> <st1:state w:st="on">Utah</st1:state> is very well known more one state of the <st1:country-region w:st="on"><st1:place w:st="on">US</st1:place></st1:country-region>. The research group of Prof Müller contributed a total of 16 poster presentations. The research team was represented by the PhD students <span class=SpellE>Aslihan</span> <span class=SpellE>Akkar</span>, Felix <span class=SpellE>Tröster</span>, Boris Petri, Anne <span class=SpellE>Saupe</span>, <span class=SpellE>Ilona</span> <span class=SpellE>Buttle</span>, <span class=SpellE>Conny</span> Keck, and <span class=SpellE>Nadim</span> <span class=SpellE>Bushrab</span>.<br> <st1:city w:st="on">Salt Lake City</st1:city> is famous for the <st1:placename w:st="on"><st1:place w:st="on">Mormon</st1:placename> <st1:placetype w:st="on">Temple</st1:placetype></st1:place> and the Adjacent Mormon Conference Centre. The Mormon Conference Centre was especially built to gather many Mormons for one big convention once a year. Of course, access to nice bars and fun is <span class=GramE>limited,</span> therefore in case you go to <st1:city w:st="on"><st1:place w:st="on">Salt Lake City</st1:city></st1:place> you should buy a <i>club card</i> to have also pleasure in the clubs during the night. All members of the research team of Prof Müller were club members from the first day. To sum up: AAPS in <st1:city w:st="on"><st1:place w:st="on">Salt Lake City</st1:city></st1:place> was a very successful meeting because new research ideas were created and research links established. </span><span lang=EN-GB style='mso-ansi-language:EN-GB'><o:p></o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:24'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal><span lang=EN-GB style='mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:25'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal><span lang=EN-GB style='mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:26'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><a href="http://www.muller-berlin.com/protest.htm"><span lang=EN-GB style='mso-ansi-language:EN-GB'>Pharmacy student protest, Dec. 1st - 5th 2003</span></a></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif";mso-ansi-language: EN-GB'> <span lang=EN-GB><o:p></o:p></span></span></p> <p class=MsoNormal style='margin-bottom:12.0pt'><span lang=EN-GB style='mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:27'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><a href="http://www.muller-berlin.com/boehringer.htm"><span lang=EN-GB style='mso-ansi-language:EN-GB'>Sept. 17th <span class=SpellE>Boehringer</span> <span class=SpellE>Ingelheim</span> - largest biotech plant Europe</span></a></span><span lang=EN-GB style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'><o:p></o:p></span></p> <p class=MsoNormal style='margin-bottom:12.0pt'><span lang=EN-GB style='mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:28'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><a href="http://www.muller-berlin.com/spielberg.htm"><span lang=EN-GB style='mso-ansi-language:EN-GB'>Sept. 7th 2003 Prof. Müller meets Spielberg in London</span></a></span><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"; mso-ansi-language:EN-GB'> <span lang=EN-GB><o:p></o:p></span></span></p> <p class=MsoNormal style='margin-bottom:12.0pt'><span lang=EN-GB style='mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p> </td> </tr> <tr style='mso-yfti-irow:29'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:10.0pt;font-family:"Verdana","sans-serif"'><a href="http://www.muller-berlin.com/jogging.htm">2003 Berlin &quot;Marathon&quot; Relay 2003</a><o:p></o:p></span></p> <p class=MsoNormal style='margin-bottom:12.0pt'><o:p>&nbsp;</o:p></p> </td> </tr> <tr style='mso-yfti-irow:30'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal><o:p>&nbsp;</o:p></p> </td> </tr> <tr style='mso-yfti-irow:31;mso-yfti-lastrow:yes'> <td style='padding:0cm 0cm 0cm 0cm'> <p class=MsoNormal><o:p>&nbsp;</o:p></p> </td> </tr> </table> </div> <p class=MsoNormal><o:p>&nbsp;</o:p></p> </div> </body> </html>